Close
Nordic 9Nordic 9

FenoMark Diagnostics (private company)

Sweden fenomark.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Health servicesPharma
Business model:B2B

FenoMark Diagnostics is a biotech startup in Sweden developing cancer treatment with robust, reliable and data rich proteomics on routinely biobanked FFPE tissue

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to FenoMark Diagnostics

Name Criteria
Iceland 3Z Pharmaceuticals
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 2
France ABC Transfer
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Norway Avexxin
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
United Kingdom Beckley Psytech
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 3
Sweden Cinclus Pharma
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 3
Sweden Gnosco
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden iCellate
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 1
Sweden Inossia
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 2
Denmark Octarine Bio
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 2
France Pharmedigroup
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 1
Top